Document 1087
 DOCN  M94A1087
 TI    1994 HIV treatment directory in France: a genuine partnership with HIV
       actors.
 DT    9412
 AU    Chambon IF; Ahouanto M; Landman R; Cohen S; Cohen B; Fontenay F;
       Rouzioux C; ARCAT-SIDA, Paris, France.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(2):211 (abstract no. PB0857). Unique
       Identifier : AIDSLINE ICA10/94371488
 AB    OBJECTIVE: For three years now, ARCAT-SIDA (NGO) have been running a HIV
       trials data collection and distribution system for information exchange
       between professionals and a wide public range. The methodology used and
       the main results obtained are presented below. METHODS: From March to
       October 1993, a systematic and huge date collection campaign was
       launched towards the ANRS, sponsoring pharmaceutical firms (24),
       hospital wards (166) and clinical investigators which participated in
       the previous issue (165). The trials retained concern persons in phase I
       to IV and omply both with French Law and the GCP. The presentation data
       sheets are drawn up by specialized physician and based on the
       information received, whereas actual editing is submitted to prior
       approval by the sponsors and the investigators. Once the trials are
       completed, the corresponding results are also collected and integrated.
       The trials in progress are presented on a double-page format. The LH
       side page describes the trial within the overall research context and
       reminds the main scientific pre-requisites. The RH side page provides
       the main technical characteristics together with a practical overview of
       the trials; this is issued both in French and in English. It also
       presents, when available, the main data on molecules (30) assessed
       during these trials. RESULTS: Almost all the French actors in the HIV
       field responded favourably (only one refusal). For the period of
       concern, 96 trials have been registered. During the year 1993, 41 trials
       were completed; they included 4505 patients and resulted in 19
       abstracts, 4 papers and 2 letters issued in scientific journals. In
       October 1993, 55 trials were in progress (Pl = 15, Ol = 21, tumoral
       diseases = 8, immunotherapy = 6, others = 5) and concerned 7556
       patients. A comprehensive table on HIV trial research in France, from
       the second term of 1992 to December 1993 is provided, together with a
       balance of information distribution and broadcast (4000 copies for the
       first issue were distributed as of December 31 1993; 5000 copies of the
       1994 issue have been edited). CONCLUSIONS: ARCAT-SIDA have set up a
       scientific information distribution and broadcasting network in France,
       thus making of each actor a real partner. ARCAT-SIDA are not an
       institutional actor and as such they have established an environment of
       trust and confidence which enhances information exchange. The ethics
       applied for information exchange, by simply distributing the information
       without any comments, has reinforced this trustworthiness. This
       presentation meets professional needs and PWA expectations in this
       field. This information exchange with our various partners will be
       continued and in 1994, ARCAT-SIDA will take an active part in the
       Inter-Act (International Aids Clinical Trials Data Base) for data
       information sharing and circulation on a worldwide scale.
 DE    *Clinical Trials  France  Human  HIV Infections/*THERAPY  *Information
       Services  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).